25
Thu, Apr
41 New Articles

B2RLaw Advises Life Science Innovation Fund on Investment in Aidlab

B2RLaw Advises Life Science Innovation Fund on Investment in Aidlab

Poland
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

B2RLaw has advised the Life Science Innovation Fund on an unspecified investment in telemedicine startup Aidlab.

Life Science Innovation Fund is a Polish venture capital fund that invests in MedTech, BioTech, and Health Care. According to B2RLaw, “the aim of the investment is to develop a new product, Aidmed, a device which remotely diagnoses diseases, particularly sleep breathing and cardiac disorders.”

B2RLaw’s team consisted of Partner Szymon Syp and Senior Associate Iga Wojtczak-Opala.

Our Latest Issue